fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Calcipotriol

All products: Limited Use (codes 191)

Dovonex · DIN 01976133 · 50 mcg/g · Oint

Limited Use, Reason for Use code 191 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 191 required
Write on scriptReason for Use code 191 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 191
Reason for Use code 191 For the treatment of psoriasis in patients who have failed topical corticosteroids alone, or are intolerant to topical corticosteroids. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Dovonex · DIN 01976133 Manufacturer: Leo Pharma Inc.; listing date 1997-04-10 Health Canada: Marketed since 1992-12-31 · brand DOVONEX · ATC D05AX02 CALCIPOTRIOL · form Ointment · route Topical · ingredients CALCIPOTRIOL 50 MCG/G · company Leo pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Dovonex: Formulary list price $1.25 per unit (the source does not state the unit; exact figure $1.2489). What the ministry pays, not the patient.

Ministry pays: $1.2489 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01976133)

Source record
DIN 01976133: Dovonex Raw flags: sec12=Y, sec3=Y Item: 843600044; group id 859; item number 2080; lccId 00119; manufacturer id LEO Source form: Oint; strength: 50mcg/g Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $1.2489; ministry $1.2489 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01976133 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13340
Shortage status: not checked (no credentials)

Other products in the same Health Canada class (D05AX): coverage varies; not interchangeable

  • Calcitriol (Silkis): limited Use 191
Other drugs in the same formulary class (84:36 Miscellaneous Skin and Mucous Membrane Agents) and how they are covered

Matched class: 84:36 Miscellaneous Skin and Mucous Membrane Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ACITRETIN, AZELAIC ACID, FLUOROURACIL, ISOTRETINOIN, ZINC SULFATE Some products covered without a code (check the product listing): COLLAGENASE 84:36 Miscellaneous Skin and Mucous Membrane Agents

CALCITRIOL

· 1 products · Limited Use, codes 191 · strengths: 3mcg/g · Oint

ACITRETIN

· 6 products · General benefit · strengths: 10mg, 25mg · Cap

AZELAIC ACID

· 1 products · General benefit · strengths: 15% · Top Gel

COLLAGENASE

· 2 products · General benefit (1), Temporary benefit (1) · strengths: 250Unit/g · 30g Pk, Oint-30g Pk

FLUOROURACIL

· 1 products · General benefit · strengths: 5% · Cr

ISOTRETINOIN

· 8 products · General benefit · strengths: 10mg, 20mg, 30mg, 40mg · Cap

ZINC SULFATE

· 2 products · General benefit · strengths: 0.5%, 10mg · Oint, Sup

ALITRETINOIN

· 4 products · Listed, not a benefit (2), Limited Use, codes 442 (2) · strengths: 10mg, 30mg · Cap

BRODALUMAB

· 1 products · Limited Use, codes 553 · strengths: 210mg/1.5mL · Inj Sol-Pref Syr

IXEKIZUMAB

· 2 products · Limited Use, codes 526 · strengths: 80mg/mL · Inj Sol-Pref Autoinj, Inj Sol-Pref Syr

PIMECROLIMUS

· 1 products · Limited Use, codes 383 · strengths: 1% · Cr

RISANKIZUMAB

· 3 products · Limited Use, codes 574 · strengths: 75mg/0.83mL, 150mg/mL · Inj Sol-0.83mL Pref Syr (Preservative-Free), Inj Sol-Pref Pen (Preservative-Free), Inj Sol-Pref Syr (Preservative-Free) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:36 and 3 more
Full class listing Related classes: 84:04 Anti-Infectives, 84:06 Anti-Inflammatory, 84:28 Keratolytic Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: download failed: DPDUnavailable